Bell Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Bell Investment Advisors's GILD Position: Q2 2026 in Review
Bell Investment Advisors reduced its Gilead Sciences (GILD) stake by 12% in Q2 2026, selling an estimated $9.22K and leaving 525 shares worth $66.3K. The position accounts for 0.01% of the portfolio, ranked #232.
Bell Investment Advisors first reported a position in GILD in Q3 2021 and has held it in 19 quarters since. The position peaked at $86.1K in Q4 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Bell Investment Advisors held 525 shares of Gilead Sciences worth $66.3K as of Q2 2026.
- Bell Investment Advisors sold 70 Gilead Sciences shares in Q2 2026, an estimated $9.22K.
- Gilead Sciences made up 0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #232 holding.
- Bell Investment Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 19 quarters since.
- Bell Investment Advisors's Gilead Sciences position peaked at $86.1K in Q4 2023.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.